Drug retention of biologics and Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study

OBJECTIVES: This multicentre retrospective study in Japan aimed to assess the retention of biological disease-modifying antirheumatic drugs and Janus kinase inhibitors (JAKi), and to clarify the factors affecting their retention in a real-world cohort of patients with rheumatoid arthritis. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebina, Kosuke, Etani, Yuki, Maeda, Yuichi, Okita, Yasutaka, Hirao, Makoto, Yamamoto, Wataru, Hashimoto, Motomu, Murata, Koichi, Hara, Ryota, Nagai, Koji, Hiramatsu, Yuri, Son, Yonsu, Amuro, Hideki, Fujii, Takayuki, Okano, Takaichi, Ueda, Yo, Katayama, Masaki, Okano, Tadashi, Tachibana, Shotaro, Hayashi, Shinya, Kumanogoh, Atsushi, Okada, Seiji, Nakata, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441119/
https://www.ncbi.nlm.nih.gov/pubmed/37597846
http://dx.doi.org/10.1136/rmdopen-2023-003160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441119/
https://www.ncbi.nlm.nih.gov/pubmed/37597846
http://dx.doi.org/10.1136/rmdopen-2023-003160

Ejemplares similares